USPTO serial 87726002
Reviewed by CopyMark Law Group
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Suzanne M. Hengl
Suzanne M. Hengl Baker Botts L.L.P.30 Rockefeller Plaza44th FloorNew York, NY 10112-4498| Class | Description | Status | First use |
|---|---|---|---|
| 001 | High purity solvents and chemicals for use in the electronics market; Aqueous acid blends for use in metal etching; Organic solvents for use in wafer surface pre-wetting prior to photoresist application; Organic chloride chemicals for use in furnace tube cleaning and silicon wafer oxidation and cleaning; [ Chemicals in the nature of infra-red absorbers for use in the manufacture of printing inks used for security printing applications for counterfeit and fraud detection; ] Unexposed x-ray film, not for medical use, used to inspect internal defects of objects such as aircraft engine parts, pipeline and valves without destruction; Unexposed photographic film | ACTIVE | Dec 1, 2015 |
| 002 | Dyes and colorants for use in the manufacture of printing inks, namely, ink-jet printing inks | ACTIVE | Dec 31, 2006 |
| 007 | Gas separating apparatus, namely, gas separators; gas separating membranes as a part of gas separating apparatus; filters for gas separating apparatus; membrane modules for gas separating apparatus; Resin plates used as printing plates; printing plates; engraving machines for resin printing plates used for flexographic printing and replacement parts therefor | ACTIVE | Nov 30, 2014 |
| 009 | Computer software program for the management and generation of patient specific image related information for use by healthcare providers for reviewing and communicating of medical history and medical images for the primary diagnosis, treatment and care of patients; [ Lenses for television and motion picture cameras; ] Film for pressure measurement, namely, film for use as a pressure indicator that changes color when pressure is applied and the color density changes according to the various pressure levels; film for pressure measurement for adjustment of pressure distribution and pressure balance purposes, namely, film for use as a pressure indicator that changes color when pressure is applied and the color density changes according to the various pressure levels; plastic sheets and plastic film for use as a pressure indicator that changes color when pressure is applied and the color density changes according to the various pressure levels; Computed radiography equipment, not for medical use, used to inspect internal defects of objects such as aircraft engine parts, pipeline and valves without destruction; Medical imaging software used for three-dimensional image visualization and analysis used by healthcare providers, namely, radiologists, cardiologists, surgeons, physician assistants, technologists and nurses for supporting diagnosis, treatment, planning and care of patients; Medical imaging software used for cardiology image management and reporting for use by healthcare providers for primary diagnosis, treatment, planning and care of patients; Downloadable medical imaging software for capturing, storing, managing, viewing, interpreting and sharing images and their associated objects, namely, reports, documents and notes, within a healthcare enterprise; Downloadable medical informatics software used to manage radiology operations and to connect outpatient workflow to enterprise imaging used by healthcare providers to support the imaging business and by patients for involvement in their own care, via a patient portal; Downloadable medical imaging software used by healthcare professionals accessed through the electronic health record, mobile or web platforms, to view images and reports for diagnosis, treatment, follow-up, and patient care coordination, enabling secure, easy-to-manage access to the complete patient imaging record throughout the healthcare enterprise [ ; Electronic storage devices in the nature of memory media for storing information for data processing installations; computer central processing unit for data processing; Video processors for use with medical and surgical apparatus and instruments ] | ACTIVE | Dec 31, 2014 |
| 010 | Medical ultrasound apparatus; ultrasound diagnostic apparatus; Medical apparatus, namely, medical ultrasound device; medical diagnostic and screening ultrasound apparatus; Medical endoscopes; Medical devices for use in endoscopy procedures, namely, enteroscope, overtubes balloon and balloon-pump controller; Flexible Bronchoscope; [ Medical and surgical apparatus and instruments, namely, light sources for medical and surgical endoscopes; ] Laboratory equipment, namely, ultrasonic processors for use in connection with ultrasonic gastroscopes and ultrasound video bronchoscope | ACTIVE | Jul 31, 2016 |
| 040 | Contract formulation for others in the field of biologic and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; Contract manufacturing for others in the nature of mammalian, bacterial, insect and yeast cell expressions in the field of biologic and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others | ACTIVE | Dec 31, 2011 |
| 042 | Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; process development, namely, development of processes for others for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; project studies for others relating to the use of mammalian cell cultures and vectors in the field of biotechnology; Research and development for others in the field of biologic products and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; Analytical and stability testing services for others in the field of biologic products and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; [ Electronic data back-up; conversion of data to electronic media; technical project management in the field of electronic data processing; electronic data storage and storage of data in computer databases; Recovery of computer data; ] providing online non-downloadable medical imaging software for capturing, storing, managing, viewing, interpreting and sharing images and their associated objects, namely, reports, documents and notes, within a healthcare enterprise; providing online non-downloadable medical informatics software used to manage radiology operations and to connect outpatient workflow to enterprise imaging used by healthcare providers to support the imaging business and by patients for involvement in their own care, via a patient portal; providing online non-downloadable medical imaging software used by healthcare professionals accessed through the electronic health record, mobile or web platforms, to view images and reports for diagnosis, treatment, follow-up, and patient care coordination, enabling secure, easy-to-manage access to the complete patient imaging record throughout the healthcare enterprise | ACTIVE | Feb 6, 2014 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Mar 17, 2025 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Mar 14, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 23, 2024 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Mar 8, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 8, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 8, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 8, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 24, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 31, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 31, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 31, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 31, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 31, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 31, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 24, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 8, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 8, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 18, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 29, 2018 | ALIE | ASSIGNED TO LIE | — |
| Mar 19, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 17, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 22, 2017 | NWAP | NEW APPLICATION ENTERED | — |